Dublin, Aug. 19, 2024 (GLOBE NEWSWIRE) -- The "Epinephrine Auto-Injection Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The Epinephrine ...

Kaléo, a global leader in drug-delivery device combinations and auto-injector innovation and the makers of the only epinephrine auto-injector with voice guidance, AUVI-Q ® (epinephrine injection), ...

AUVI-Q® (epinephrine injection, USP) was cleared for use as a part of Axiom Mission 4 that took flight on June 25, 2025. · GlobeNewswire Inc. Richmond, Virginia, July 24, 2025 (GLOBE NEWSWIRE) -- ...

ALLERGY sufferers have been warned to return Emerade adrenaline pens to their pharmacy after specific batches failed to work. If you have an Emerade 300 or 500 mcg adrenaline autoinjector – or you ...

MHRA has issued a drug alert for the Emerade adrenaline auto-injector device, as a result of the device’s potential to fail in delivery of the dose due to blockage of the needle. The Medicines and ...

Sanofi has launched a voice-guided epinephrine auto-injector Auvi-Q in the US to provide emergency treatment for life-threatening allergic reactions in people who are at risk for, or have a history of ...

Please provide your email address to receive an email when new articles are posted on . Epinephrine autoinjectors may have little effect on surviving anaphylaxis events. Research is needed in ...

First generic version of Epinephrine 1mg/1mL vial in U.S. market LAKE ZURICH, Ill., December 17, 2024--(BUSINESS WIRE)--Fresenius Kabi, an operating company of Fresenius, announced today that ...

ALLERGY sufferers are being urged to check their adrenaline pens after health bosses warned there may be a fault with a batch of injectors. Health bosses say there is a risk of some Emerade pens ...